Clinical decision making with immunotherapies in advanced or recurrent endometrial cancer

In this activity, a gynaecological oncologist considers the expanding role of molecular classification in endometrial cancer and provides an update on the use of immune checkpoint inhibitors to treat patients with advanced or recurrent disease, including key guideline recommendations, supporting data and considerations for clinical practice.
Watch now: touchoncologyime.org/immunoth...
Or sign up today to stay informed:touchoncology.com/your-free-1...
This activity is funded by an independent medical education grant from Merck & Co, Inc. This activity is jointly provided by USF Health and touchIME.